- Manuel Amieva, M.D., Ph.D., Receives $150,000 Grant for
Pediatric Research -
WASHINGTON, May 18 /PRNewswire-FirstCall/ -- The Pediatric Infectious
Diseases Society (PIDS), on behalf of MedImmune, Inc. (Nasdaq: MEDI),
presented the MedImmune Career Development Award in Pediatric Infectious
Disease to Manuel Amieva, M.D., Ph.D., of Stanford University School of
Medicine. The award, which includes a $50,000 per year grant for up to three
years, was established to support the development of outstanding physician-
scientists as independent investigators in the field of pediatric infectious
diseases, aiming to foster their research productivity in their initial years
as faculty. PIDS presented the award to Dr. Amieva on May 16 at a dinner
coinciding with the annual meeting of the Pediatric Academic Societies in
"The career development award is an extension of MedImmune's commitment to
the pediatric research community," said Alan H. Cohen, M.D., FAAP, FCCP,
Senior Director of Medical Affairs at MedImmune, Inc. "Each year, thousands of
children and adults suffer from illnesses caused by viral and bacterial
respiratory pathogens. Dr. Amieva's research over the next three years may
lead to new and important discoveries in pediatric infectious illnesses,
benefiting all children."
The Research Affairs Committee of PIDS selected Dr. Amieva based on his
scientific accomplishments and the quality of his research proposal. Eligible
applicants were required to be trained in pediatric infectious diseases, to
have completed three years of fellowship training, to be engaged in laboratory
research and to hold a full-time academic position.
"The review committee selected Dr. Amieva to receive the career
development award based on his outstanding commitment to research in the area
of pediatric infectious diseases and his promise for success," commented
Joseph St. Geme, M.D, president, Pediatric Infectious Diseases Society. "Dr.
Amieva is most deserving, and we are pleased that this funding will support
his continued work on the relationship between Helicobacter pylori infection
Dr. Amieva is an Assistant Professor of Pediatrics, Microbiology and
Immunology at Stanford University School of Medicine, where he received his
medical degree and Ph.D. in cancer biology. Dr. Amieva is from Mexico City,
About MedImmune, Inc.
MedImmune strives to provide better medicines to patients, new medical
options for physicians, rewarding careers to employees, and increased value to
shareholders. Dedicated to advancing science and medicine to help people live
better lives, the company is focused on the areas of infectious diseases,
cancer and inflammatory diseases. With approximately 2,000 employees
worldwide, MedImmune is headquartered in Maryland. For more information, visit
the company's website at http://www.medimmune.com.
SOURCE MedImmune, Inc.
Clarencia Stephen of MedImmune, Inc.